Esketamine monotherapy is linked to greater 28-day symptom reduction in treatment-resistant depression vs placebo, new research shows.

Market reaction to recent readouts from Compass Pathways and Beckley Psytech/atai in treatment-resistant depression speaks to ...

Johnson & Johnson announced that it has submitted a supplemental new drug application for the approval of esketamine nasal spray as a monotherapy for adults with treatment-resistant depression.If ...

The FDA approved esketamine (Spravato) nasal spray as monotherapy for adults with treatment-resistant depression who had an inadequate response to at least two oral antidepressants, maker Johnson ...

One in five adults said they experienced any symptoms of anxiety or depression in a 2-week period, according to a 2022 CDC survey. The FDA updated a warning on the label of esketamine nasal spray ...

Esketamine is a relatively new therapy, for treatment-resistant depression. It's administered as a nasal spray known as Spravato with a pre-loaded dose of medication.

Licensed Professional Counselor Yvette Bunting-Watts puts it simply: “No one enjoys feeling the lack of joy.” Bunting-Watts, knows the topic of mental health well, as she is the founder and CEO of ...

Esketamine monotherapy was found to significantly improve depressive symptoms in patients with treatment-resistant depression. Johnson & Johnson is seeking to expand the approval of Spravato ...

Esketamine, a form of ketamine taken as a nasal spray, has been approved for the treatment for moderate to severe treatment-resistant depression in Scotland but intravenous ketamine has not, though it ...

SPRAVATO® (esketamine) approved in the U.S. as the first and only monotherapy for adults with treatment-resistant depression ...

Clinics offering ketamine infusions and injections for “treatment-resistant depression” are today claiming 24-48 hours remission, and ketamine is also being marketed for post-traumatic stress ...

Spravato, a ketamine nasal spray, is being subsidized for treatment-resistant depression. Learn about its benefits, usage, and eligibility criteria.